Yu-Hong Chen Selected Research

Yu-Hong Chen Research Topics

Disease

38	Leukemia 05/2022 - 04/2006
28	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 04/2006
27	Residual Neoplasm 01/2022 - 07/2008
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2012
17	Infections 01/2022 - 12/2004
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2011
12	Neoplasms (Cancer) 01/2022 - 07/2008
11	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 04/2004
11	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 07/2008
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 08/2008
8	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2010
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 08/2008
7	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2011
6	Philadelphia Chromosome 01/2020 - 01/2011
5	Hematologic Diseases (Blood Diseases) 11/2020 - 08/2009
4	Thrombotic Microangiopathies 01/2022 - 04/2006
4	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
4	Viremia 10/2017 - 01/2007
3	Hemorrhage 01/2022 - 01/2007
3	Pneumonia (Pneumonitis) 10/2021 - 06/2009
3	Hemorrhagic Cystitis 07/2018 - 01/2007
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2015 - 12/2007
2	Neoplasm Metastasis (Metastasis) 12/2021 - 10/2021
2	Triple Negative Breast Neoplasms 11/2021 - 01/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Stroke (Strokes) 01/2021 - 11/2020
2	Disease Progression 01/2021 - 01/2019
2	Carcinogenesis 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 03/2011
2	Hepatitis 01/2019 - 04/2008
2	Melanoma (Melanoma, Malignant) 01/2019 - 08/2016
2	Demyelinating Diseases (Demyelinating Disease) 08/2018 - 03/2013
1	Proteinuria 12/2021
1	Anemia 12/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Aspiration Pneumonia 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2021

Drug/Important Bio-Agent (IBA)

12	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2008
7	InterferonsIBA 01/2022 - 11/2015
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 04/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2016
3	Phosphotransferases (Kinase)IBA 12/2021 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2008
3	SteroidsIBA 01/2020 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2018
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2011
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	BilirubinIBA 01/2022 - 12/2021
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021 - 01/2019
2	AntigensIBA 11/2021 - 08/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 03/2011
2	CytokinesIBA 10/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
2	AntibodiesIBA 11/2020 - 01/2019
2	Prostaglandins FIBA 03/2020 - 10/2015
2	Basiliximab FDA Link 01/2020 - 01/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 08/2017
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
2	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2011
2	Methotrexate (Mexate)FDA LinkGeneric 08/2011 - 07/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2008 - 07/2008
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008 - 05/2008
1	Beclin-1IBA 12/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2021
1	atezolizumabIBA 11/2021
1	bafilomycin A1IBA 10/2021
1	Conditioned Culture MediaIBA 10/2021
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 10/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2021
1	InflammasomesIBA 10/2021
1	Tartrate-Resistant Acid PhosphataseIBA 10/2021
1	Autophagy-Related Protein-1 HomologIBA 10/2021
1	trametinibIBA 10/2021
1	Cycloheximide (Cicloheximide)IBA 10/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	ChromatinIBA 01/2021
1	sodium bisulfide (NaHS)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	olaratumabIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021

Therapy/Procedure

92	Hematopoietic Stem Cell Transplantation 05/2022 - 01/2007
38	Transplantation 01/2022 - 04/2004
20	Stem Cell Transplantation 01/2022 - 06/2012
20	Therapeutics 01/2022 - 01/2007
12	Drug Therapy (Chemotherapy) 01/2020 - 12/2007
6	Immunotherapy 01/2022 - 08/2016
5	Haploidentical Transplantation 01/2021 - 01/2016
5	Cell Transplantation 01/2018 - 04/2006
2	Aftercare (After-Treatment) 01/2021 - 11/2018
2	Consolidation Chemotherapy 03/2019 - 01/2016
2	Induction Chemotherapy 12/2016 - 01/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2013 - 02/2009
1	Plasma Exchange 01/2022
1	Homologous Transplantation 01/2022
1	Cannula 01/2021